China Traditional Chinese Medicine Holdings Co. Limited (HKG:0570)
Hong Kong
· Delayed Price · Currency is HKD 1.990
0.00 (0.00%)
Apr 3, 2025, 4:08 PM HKT
HKG:0570 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 16,510 | 18,122 | 14,304 | 19,053 | 14,806 | Upgrade
|
| Revenue Growth (YoY) | -8.90% | 26.69% | -24.92% | 28.68% | 3.39% | Upgrade
|
| Cost of Revenue | 8,653 | 8,847 | 7,106 | 7,224 | 5,680 | Upgrade
|
| Gross Profit | 7,856 | 9,274 | 7,198 | 11,829 | 9,126 | Upgrade
|
| Selling, General & Admin | 6,477 | 7,447 | 5,549 | 8,556 | 6,294 | Upgrade
|
| Research & Development | 596.01 | 685.63 | 611.83 | 694.44 | 550.47 | Upgrade
|
| Other Operating Expenses | -74.24 | -216.48 | -147.74 | -146.05 | -232.7 | Upgrade
|
| Operating Expenses | 7,104 | 7,926 | 6,023 | 9,120 | 6,652 | Upgrade
|
| Operating Income | 751.9 | 1,349 | 1,175 | 2,709 | 2,474 | Upgrade
|
| Interest Expense | -171.54 | -199.05 | -220.7 | -222.03 | -244.67 | Upgrade
|
| Interest & Investment Income | 47.68 | 65.26 | 67.27 | 62.58 | 47.6 | Upgrade
|
| Earnings From Equity Investments | -0.95 | -3.7 | -3.48 | -10.75 | -15.87 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.8 | -0.38 | -0.12 | 0.77 | -1.34 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.85 | 0.79 | 0.83 | 1.33 | -13.27 | Upgrade
|
| EBT Excluding Unusual Items | 628.04 | 1,212 | 1,019 | 2,541 | 2,246 | Upgrade
|
| Impairment of Goodwill | -431.83 | - | -35.87 | -29.78 | -16.84 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.36 | - | - | - | 0.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.29 | 33.72 | 4.75 | 24.53 | 0.09 | Upgrade
|
| Asset Writedown | -32.18 | -20.77 | -147.53 | -15.51 | - | Upgrade
|
| Pretax Income | 163.11 | 1,225 | 840.11 | 2,520 | 2,230 | Upgrade
|
| Income Tax Expense | 142.34 | -171.54 | 119.14 | 396.86 | 369.45 | Upgrade
|
| Earnings From Continuing Operations | 20.77 | 1,396 | 720.97 | 2,123 | 1,861 | Upgrade
|
| Net Income to Company | 20.77 | 1,396 | 720.97 | 2,123 | 1,861 | Upgrade
|
| Minority Interest in Earnings | 33.3 | -110.87 | 43.52 | -190.57 | -197.39 | Upgrade
|
| Net Income | 54.07 | 1,285 | 764.49 | 1,933 | 1,663 | Upgrade
|
| Net Income to Common | 54.07 | 1,285 | 764.49 | 1,933 | 1,663 | Upgrade
|
| Net Income Growth | -95.79% | 68.11% | -60.45% | 16.21% | 4.73% | Upgrade
|
| Shares Outstanding (Basic) | 5,036 | 5,036 | 5,036 | 5,036 | 5,036 | Upgrade
|
| Shares Outstanding (Diluted) | 5,036 | 5,036 | 5,036 | 5,036 | 5,036 | Upgrade
|
| EPS (Basic) | 0.01 | 0.26 | 0.15 | 0.38 | 0.33 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.26 | 0.15 | 0.38 | 0.33 | Upgrade
|
| EPS Growth | -95.79% | 68.11% | -60.45% | 16.21% | 4.73% | Upgrade
|
| Free Cash Flow | - | 684.88 | 568.58 | 8.94 | -901.14 | Upgrade
|
| Free Cash Flow Per Share | - | 0.14 | 0.11 | 0.00 | -0.18 | Upgrade
|
| Dividend Per Share | 0.003 | - | 0.045 | 0.114 | - | Upgrade
|
| Dividend Growth | - | - | -60.16% | - | - | Upgrade
|
| Gross Margin | 47.59% | 51.18% | 50.32% | 62.09% | 61.64% | Upgrade
|
| Operating Margin | 4.55% | 7.44% | 8.21% | 14.22% | 16.71% | Upgrade
|
| Profit Margin | 0.33% | 7.09% | 5.34% | 10.14% | 11.23% | Upgrade
|
| Free Cash Flow Margin | - | 3.78% | 3.98% | 0.05% | -6.09% | Upgrade
|
| EBITDA | 1,824 | 2,421 | 2,216 | 3,505 | 3,115 | Upgrade
|
| EBITDA Margin | 11.05% | 13.36% | 15.49% | 18.39% | 21.04% | Upgrade
|
| D&A For EBITDA | 1,072 | 1,072 | 1,041 | 795.72 | 641.13 | Upgrade
|
| EBIT | 751.9 | 1,349 | 1,175 | 2,709 | 2,474 | Upgrade
|
| EBIT Margin | 4.55% | 7.44% | 8.21% | 14.22% | 16.71% | Upgrade
|
| Effective Tax Rate | 87.27% | - | 14.18% | 15.75% | 16.57% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.